EP4028010
VS-6063 IN COMBINATION WITH CH5126766 FOR THE TREATMENT OF CANCER
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
11.9.2020EP published:
8.4.2026EP application number:
20772249.7
EPO information:
European Patent Register
Max expiry date:
10.9.2040Expiry date:
10.9.2026
Title in English:
VS-6063 IN COMBINATION WITH CH5126766 FOR THE TREATMENT OF CANCERLanguage of the patent:
English
Timeline
Today
11.9.2020EP application
8.4.2026EP Publication
10.9.2026Expires
Owner
Name:
The Institute of Cancer Research: Royal Cancer HospitalAddress:
123 Old Brompton Road, London SW7 3RP, GB
Inventor
Name:
BANERJI, UdaiAddress:
London SW7 3RP, GB
Priority
Number:
PCT/EP2019/074565Date:
13.9.2019Country:
WO
Classification
Categories:
A61K 31/506, A61P 35/00